Visit Invest in Denmark’s booth (no. 40) to hear about one of the strongest Life Sciences clusters in Europe. Denmark offers leading drug development with the third-largest commercial pipeline, some of the best framework conditions in Europe for doing clinical research and a new National Biobank Register.
Monday morning session with Leif Helth Jensen from CAT Science:
Session Title: Crucial decisions around asset valuation and deal terms
Date: Monday, November 12, 2012
Room: Level 2, Room F
Leif Helth Jensen from CAT Science holds experience from therapeutic research and development. He has previously been working, or is currently working, as researcher, CEO, member or Chairman of the Board of Directors in a number of Biotech companies. Leif Helth Jensen is co-founder of NeuroSearch, Zealand Pharma and Cureon (Santaris Pharma).
Danish hotdogs and beer from 16.00 Monday and Tuesday at Invest in Denmark's booth!
For more information, please contact Investment Managers; Kristoffer Rørbæk, email@example.com, Niels Onteniente, firstname.lastname@example.org, or Lise Pape, email@example.com,
Click to learn more about the BIO-Europe conference.